Singapore Medical Group buys 85% stake in SW1 Clinic
Add BT as a preferred source
Nisha Ramchandani
DeeperDive is a beta AI feature. Refer to full articles for the facts.
SINGAPORE Medical Group (SMG) is acquiring an 85 per cent stake in local aesthetics clinic SW1 for up to S$6.5 million.
The amount will be funded through the issuance of some 6.05 million new shares at S$0.578 per share and up to S$3 million in cash over three years.
Located in Paragon Medical Centre, SW1 was set up by the founders of The Sloane Clinic, Low Chai Ling and Kenneth Lee, in December last year . The 7,000 square foot centre, which has a team of five medical aesthetics practitioners and one plastic surgeon, broke even within the first two months of operations, SMG said.
SMG's chief executive officer Beng Teck Liang said: "Our immediate next steps would be to scale the business, starting with countries such as Vietnam and Indonesia where we already have a footprint. We also have plans to penetrate new geographies such as Malaysia, which will serve as another gateway for regional expansion."
Copyright SPH Media. All rights reserved.
TRENDING NOW
Shelving S$5 billion office redevelopment plan proved ‘wise’ as geopolitical risks mount: OCBC chairman
China pips the US if Asean is forced to choose, but analysts warn against reading it like a sports result
Beijing’s calculated silence on the Iran war
Middle East-linked energy supply shocks put Asean Power Grid back in focus
